Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Interest Expenses (2019 - 2025)

Historic Interest Expenses for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $805000.0.

  • Pulmonx's Interest Expenses fell 965.21% to $805000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 960.78%. This contributed to the annual value of $3.5 million for FY2024, which is 850.87% up from last year.
  • As of Q3 2025, Pulmonx's Interest Expenses stood at $805000.0, which was down 965.21% from $799000.0 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Interest Expenses ranged from a high of $905000.0 in Q4 2023 and a low of $198000.0 during Q1 2022
  • Over the past 5 years, Pulmonx's median Interest Expenses value was $781000.0 (recorded in 2025), while the average stood at $580000.0.
  • Per our database at Business Quant, Pulmonx's Interest Expenses tumbled by 8123.3% in 2021 and then soared by 28744.39% in 2023.
  • Pulmonx's Interest Expenses (Quarter) stood at $199000.0 in 2021, then soared by 80.4% to $359000.0 in 2022, then skyrocketed by 152.09% to $905000.0 in 2023, then decreased by 6.96% to $842000.0 in 2024, then dropped by 4.39% to $805000.0 in 2025.
  • Its last three reported values are $805000.0 in Q3 2025, $799000.0 for Q2 2025, and $781000.0 during Q1 2025.